YD Bio Limited Ordinary Shares (YDES) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

YD Bio Limited Ordinary Shares (YDES) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $450.5M, listed on NASDAQ, employing roughly 14 people, carrying a beta of -0.12 to the broader market. YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. Led by Ethan Shen, public since 2025-08-29.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for YDES as of 2026-10-16; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →